Sleep problems in ADHD - neurophysiological correlates
Sleep problems in 5-13 year olds with ADHD correlated weakly, but statistically significantly, with maternal mental health problems.1
Further information on sleep problems can be found here:
- More on the topic Sleep problems with ADHD (as ADHD symptoms) In the chapter Symptoms of ADHD.
- More on the topic (Treatment of) sleep problems with ADHD In the chapter Treatment of ADHD.
- 1. Neurotransmitters and sleep/wake regulation
- 2. Cytokines and sleep problems
- 3. Other substances involved in sleep-wake regulation
- 4. EEG peculiarities during sleep in ADHD
- 5. Immunological Consequences of Sleep Problems
1. Neurotransmitters and sleep/wake regulation
A number of neurotransmitters are involved in sleep/wake regulation in the brain.
- Serotonin2345
- Noradrenaline26
- Noradrenaline administration into the ventromedial hypothalamus of lean, insulin-sensitive animals, which increased noradrenaline there to the level of obese, insulin-resistant animals, led to complete cardiometabolic syndrome (including leptin resistance) within a few days, with no change in food intake. Additional administration of serotonin intensified this noradrenaline response7
- Histamine6
- Acetylcholine86
- GABA94
- Glutamate6
- Dopamine1011
- Dopamine metabolism and dopamine receptor abnormalities are also involved in excessive daytime sleepiness (e.g. narcolepsy)12
- Selective dopamine reuptake inhibitors promote wakefulness better than selective noradrenaline reuptake inhibitors in normal and narcoleptic animals13
- Severe sleep disorders often occur in people with ADHD or Huntington’s disease who have dopaminergic dysfunction1415
- Sleep disorders are associated with ADHD16
- DAT gene variants appear to predispose humans to a susceptibility to sleep-wake disorders10
- Dopamine and melatonin are involved in the regulation of tiredness and sleep.
The dopaminergic system is influenced by the circadian system.1718
Dopamine is produced rhythmically in the amacrine cells of the retina. The retina is controlled by dopamine in the same way as melatonin. The retina transmits light information to the suprachiasmatic nucleus, which is the master biological clock. The suprachiasmatic nucleus sends timing information for the rhythmic regulation of dopaminergic brain regions and the behavior controlled by them (locomotion, motivation). The dopamine produced in the substantia nigra and the ventral tegmentum is possibly rhythmically regulated by the suprachiasmatic nucleus via various neural pathways (including the orexin system or the medial preoptic nucleus of the hypothalamus).19 Orexin deficiency is a possible cause of narcolepsy. ⇒ Orexin / hypocretin The light absorption of the retina influences the circadian rhythm. Changes in light and light rhythm can affect the circadian rhythm.20
Dopamine and melatonin inhibit each other.21
Dopamine is mainly released early in the morning and during the day. Melatonin is inhibited by daylight and is mainly released in the evening and at night.22
Reduced extracellular dopamine (as is typical of ADHD) could therefore result in insufficient melatonin inhibition. This could possibly explain the severe daytime sleepiness reported by some people with ADHD.
Disorders of the retina are discussed as to whether they cause the shifts in chronorhythm that are common in ADHD and whether they could be a major cause of ADHD.23
1.1. Noradrenaline and circadian rhythm
Noradrenaline is said to be a key synchronizer of the circadian rhythm. Noradrenaline regulates the nocturnal release of melatonin and circadian gene expression.2425
At the same time, prolonged sleep deprivation appears to cause lasting damage to the locus coeruleus, which would cause permanent damage to the noradrenergic system26
1.2. Stress systems and circadian rhythm
Chronic stress (which we believe mediates its symptoms through very similar neurotransmitter shifts to ADHD) often leads to a disorder of the circadian system. More on this at ⇒ Changes in the circadian system due to chronic stress In the article ⇒ Stress damage due to early / prolonged stress in the section ⇒ ADHD as a chronic stress regulation disorder in the chapter ⇒ Stress.
1.3. Dopamine and circadian rhythm
The release of dopamine is subject to a circadian rhythm. See under Dopaminergic circadian and ultradian rhythms In the article The 6 dopaminergic systems of the brain in the subsection Dopamine in the section Neurotransmitters in ADHD in the chapter Neurological aspects.
2. Cytokines and sleep problems
Sleep problems correlate with increased levels of pro-inflammatory cytokines. Cytokines regulate sleep. Cytokines released by immune cells, particularly interleukin-1β and tumor necrosis factor-α, influence neuronal activity, behavior (including sleep), hormone release, and autonomic function by targeting neuroendocrine, autonomic, limbic, and cortical areas of the CNS.27 One study found elevated inflammatory markers only in women (not men) with sleep problems.28
Sleep deprivation and disturbed sleep lead to increased levels of IL-6, tumor necrosis factor (TNF) (only in men) and C-reactive protein (CRP) compared to undisturbed sleep phases.293031
Sleep problems apparently increase IL-6 and soluble intercellular adhesion molecule (slCAM) even more than severe depression.32
Sleep deprivation correlates with increased IL-6 levels, although the stimulatory effect of catecholamines on IL-6 secretion is reduced; this change may result from the concomitant reduction in cortisol-induced inhibition, which is eliminated by a lack of cortisol. The stress hormones noradrenaline and CRH also increase IL-633
3. Other substances involved in sleep-wake regulation
- Melatonin
For more details, visit ⇒ Melatonin for ADHD In the subsection ⇒ Sleep disorder-related medications for ADHD in the section ⇒ Medication for ADHD - Overview / ⇒ MELATONIN Suitable medication for ADHD in the chapter ⇒ Treatment - GHRH has a sleep-promoting effect3435
- The D1 receptor in the bovine hypothalamus mediated a 50% reduction in GHRH release from the hypothalamus in vitro36
- Orexin (hypocretin)6
- Neuropeptide
- Adenosine35
- Nucleoside
- Blocks the release of activating neurotransmitters, e.g:
- Noradrenaline
- Dopamine
- Acetylcholine
- Proinflammatory cytokines35
- Prostaglandin D235
- CRH has a sleep-inhibiting effect34 and impairs deep sleep.37 Sleep problems could therefore be a direct consequence of an overactivated HPA axis.
4. EEG peculiarities during sleep in ADHD
There are reports of specific EEG peculiarities in ADHD.38
ADHD correlated with significantly reduced microstate D in the resting EEG and a lower probability of a transition from microstate C to D. However, this was independent of sleep problems.39
4.1. Sleeping spindles
While more sleep spindles (higher sigma power) in the EEG correlated with a higher IQ in unaffected people in the light sleep phase (sleep phase 2), fewer sleep spindles correlated with ADHD.40
In contrast, another study found increased amplitude, duration, density and activity of slow-wave sleep spindles in children with ADHD.41
4.2. Gamma connectivity altered during light sleep in ADHD
Children with ADHD showed an altered gamma phase delay index in light sleep.42
4.3. Slow waves in the EEG reduced in non-REM deep sleep in ADHD
Children and adolescents with ADHD-HI showed a reduction in the EEG power of low-frequency waves from 1 to 4.5 Hz (SWA) in non-REM deep sleep throughout the brain by over 20 % compared to healthy controls. Regular use of stimulants eliminated this deviation. Assuming that SWA reflects synaptic density, this is consistent with previous neuroimaging studies that found smaller gray matter volumes in people with ADHD-HI and their normalization with regular stimulant use.43
5. Immunological Consequences of Sleep Problems
Both single and chronic sleep fragmentation increased the mRNA and protein levels of cytokines in the body tissue of mice. Changes in inflammatory responses reflected the activation of stress axes with increased corticosterone and noradrenaline. Treatment with 6-OHDA significantly reduced the inflammation caused by sleep fragmentation. This indicates a regulation of sleep fragmentation-induced inflammation in body tissue by the autonomic nervous system (sympathetic/parasympathetic nervous system).
Chronic sleep fragmentation showed more severe Consequences than single (acute) sleep fragmentation. A one-week recovery from sleep fragmentation sufficiently alleviated the peripheral inflammatory responses, but not the noradrenergic responses.44
Martin, Papadopoulos, Rinehart, Sciberras (2019): Associations Between Child Sleep Problems and Maternal Mental Health in Children with ADHD. Behav Sleep Med. 2019 Nov 25:1-14. doi: 10.1080/15402002.2019.1696346. ↥
Steriade, McCarley (1990): Brainstem control of wakefulness and sleep, S. 185 ↥ ↥
Roehrs, Carskadon, Dement, Roth (2000): Daytime Sleepiness and Alertness. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 42 ↥
Jones (2000): Basic mechanisms of sleep–wake states In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 134 ↥ ↥
McGinty, Ronald (2000): Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 64 ↥
McGinty, Ronald (2000): Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 65 ↥ ↥ ↥ ↥ ↥
Cincotta AH (2023): Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects. Int J Mol Sci. 2023 Aug 26;24(17):13255. doi: 10.3390/ijms241713255. PMID: 37686060; PMCID: PMC10487918. REVIEW ↥
Steriade, McCarley (1990): Brainstem control of wakefulness and sleep, S. 164 ↥
Steriade, McCarley (1990): Brainstem control of wakefulness and sleep ↥
Wisor, Nishino, Sora, Uhl, Mignot, Edgar (2001): Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 2001 Mar 1;21(5):1787-94. doi: 10.1523/JNEUROSCI.21-05-01787.2001. PMID: 11222668; PMCID: PMC6762940. ↥ ↥
McGinty, Ronald (2000):Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 65 ↥
Nishino, Mignot (1997): Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol. 1997 May;52(1):27-78. doi: 10.1016/s0301-0082(96)00070-6. PMID: 9185233. REVIEW ↥
Nishino, Mao, Sampathkumaran, Shelton (1998): Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online. 1998;1(1):49-61. PMID: 11382857. ↥
Zhang, Ren, Yang, Zhou, Li, Shi, Lu, Sanford, Tang (2019). Sleep in Huntington’s disease: a systematic review and meta-analysis of polysomongraphic findings. Sleep. 2019 Oct 9;42(10):zsz154. doi: 10.1093/sleep/zsz154. PMID: 31328779; PMCID: PMC6783889. METASTUDIE ↥
Wiegand, Möller, Lauer, Stolz, Schreiber, Dose, Krieg (1991): Nocturnal sleep in Huntington’s disease. J Neurol. 1991 Jul;238(4):203-8. doi: 10.1007/BF00314781. PMID: 1832711. ↥
Corkum, Moldofsky, Hogg-Johnson, Humphries, Tannock (1999): Sleep problems in children with attention-deficit/hyperactivity disorder: impact of subtype, comorbidity, and stimulant medication. J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1285-93. doi: 10.1097/00004583-199910000-00018. PMID: 10517062. ↥
Parekh, Ozburn, McClung (2015): Circadian clock genes: effects on dopamine, reward and addiction. Alcohol. 2015 Jun;49(4):341-9. doi: 10.1016/j.alcohol.2014.09.034. ↥
Baltazar, Coolen, Webb (2013): Diurnal rhythms in neural activation in the mesolimbic reward system: critical role of the medial prefrontal cortex. Eur J Neurosci. 2013 Jul;38(2):2319-27. doi: 10.1111/ejn.12224. ↥
Mendoza, Challet (2014): Circadian insights into dopamine mechanisms. Neuroscience. 2014 Dec 12;282:230-42. doi: 10.1016/j.neuroscience.2014.07.081. ↥
Wirz-Justice, Wever, Aschoff (2004): Seasonality in freerunning circadian rhythms in man. Naturwissenschaften. 1984 Jun;71(6):316-9. ↥
Green, Besharse (2004): Retinal circadian clocks and control of retinal physiology. J Biol Rhythms. 2004 Apr;19(2):91-102. ↥
Iuvone, Tosini, Pozdeyev, Haque, Klein, Chaurasia (2005): Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. Prog Retin Eye Res. 2005 Jul;24(4):433-56. ↥
Bijlenga, Vollebregt, Kooij, Arns (2019): The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD? Atten Defic Hyperact Disord. 2019 Mar;11(1):5-19. doi: 10.1007/s12402-018-0271-z. ↥
Simonneaux, Ribelayga (2003): Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 2003 Jun;55(2):325-95. doi: 10.1124/pr.55.2.2. PMID: 12773631. REVIEW ↥
Palm, Uzoni, Simon, Fischer, Coogan, Tucha, Thome, Faltraco (2021): Evolutionary conservations, changes of circadian rhythms and their effect on circadian disturbances and therapeutic approaches. Neurosci Biobehav Rev. 2021 Jun 5;128:21-34. doi: 10.1016/j.neubiorev.2021.06.007. PMID: 34102148. REVIEW ↥
Zamore Z, Veasey SC (2022): Neural consequences of chronic sleep disruption. Trends Neurosci. 2022 Sep;45(9):678-691. doi: 10.1016/j.tins.2022.05.007. PMID: 35691776; PMCID: PMC9388586. REVIEW ↥
Lorton, Lubahn, Estus, Millar, Carter, Wood, Bellinger (2006): Bidirectional Communication between the Brain and the Immune System: Implications for Physiological Sleep and Disorders with Disrupted Sleep, Neuroimmunomodulation 2006;13:357–374, https://doi.org/10.1159/000104864 ↥
Suarez (2008): Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun. 2008 Aug;22(6):960-8. doi: 10.1016/j.bbi.2008.01.011. ↥
Meier-Ewert, Ridker, Rifai, Regan, Price, Dinges, Mullington (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004 Feb 18;43(4):678-83. n = 20 ↥
Vgontzas, Papanicolaou, Bixler, Lotsikas, Zachman, Kales, Prolo, Wong, Licinio, Gold, Hermida, Mastorakos, Chrousos (1999): Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999 Aug;84(8):2603-7. ↥
Vgontzas, Zoumakis, Bixler, Lin, Follett, Kales, Chrousos (2004): Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004 May;89(5):2119-26. ↥
Motivala, Sarfatti, Olmos, Irwin (2005): Inflammatory markers and sleep disturbance in major depression. Psychosom Med. 2005 Mar-Apr;67(2):187-94. ↥
Chrousos (2009): Stress and disorders of the stress system. Nat Rev Endocrinol. 2009 Jul;5(7):374-81. doi: 10.1038/nrendo.2009.106. PMID: 19488073. REVIEW ↥
Ehlers, Reed, Henriksen (1986): Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology. 1986;42(6):467-74. doi: 10.1159/000124489. PMID: 3084988. ↥ ↥
McGinty, Ronald (2000): Neural Control of Sleep in Mammals. In: Kryger, Roth, Dement (Hrsg.): Principles and practice of sleep medicine. S. 75 ↥ ↥ ↥ ↥
West, Lookingland, Tucker (1997): Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation. Domest Anim Endocrinol. 1997 Sep;14(5):349-57. doi: 10.1016/s0739-7240(97)00031-3. PMID: 9347255. ↥
Steiger (2002): Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Med Rev. 2002 Apr;6(2):125-38. ↥
Gorgoni, Scarpelli, Reda, De Gennaro (2019): Sleep EEG oscillations in neurodevelopmental disorders without intellectual disabilities. Sleep Med Rev. 2019 Oct 30;49:101224. doi: 10.1016/j.smrv.2019.101224. ↥
Piao T, Wu G, Zhu Y, Zhong S, Dang C, Feng Y, Yang C, Wang Y, Wang C, Sun L (2025): Resting-state microstate dynamics abnormalities in children with ADHD and co-occurring sleep problems. Sleep Med. 2025 Apr;128:1-11. doi: 10.1016/j.sleep.2025.01.027. PMID: 39874815. ↥
Bestmann, Conzelmann, Baving, Prehn-Kristensen (2019): Associations between cognitive performance and sigma power during sleep in children with attention-deficit/hyperactivity disorder, healthy children, and healthy adults. PLoS One. 2019 Oct 24;14(10):e0224166. doi: 10.1371/journal.pone.0224166. eCollection 2019. n = 56 ↥
Özbudak P, Özaslan A, Temel EÜ, Güney E, Serdaroğlu A, Arhan E. New Electrographic Marker? Evaluation of Sleep Spindles in Children with Attention Deficit Hyperactivity Disorder. Clin EEG Neurosci. 2022 Oct 19:15500594221134025. doi: 10.1177/15500594221134025. PMID: 36259661. n = 67 ↥
Ueda, Takeichi, Kaga, Oguri, Saito, Nakagawa, Maegaki, Inagaki (2019): Atypical gamma functional connectivity pattern during light sleep in children with attention deficit hyperactivity disorder. Brain Dev. 2019 Nov 21. pii: S0387-7604(19)30510-8. doi: 10.1016/j.braindev.2019.11.001. ↥
Furrer, Jaramillo, Volk, Ringli, Aellen, Wehrle, Pugin, Kurth, Brandeis, Schmid, Jenni, Huber (2019): Sleep EEG slow-wave activity in medicated and unmedicated children and adolescents with attention-deficit/hyperactivity disorder. Transl Psychiatry. 2019 Nov 28;9(1):324. doi: 10.1038/s41398-019-0659-3. n = 136 ↥
Mishra, Pullum, Thayer, Plummer, Conkright, Morris, O’Hara, Demas, Ashley (2020): Chemical sympathectomy reduces peripheral inflammatory responses to acute and chronic sleep fragmentation. Am J Physiol Regul Integr Comp Physiol. 2020 Mar 4. doi: 10.1152/ajpregu.00358.2019. PMID: 32130024. ↥